Oxaliplatin

Sold as Oxaliplatin "ebewe", Goxyral, Intas-oxaliplatin, Oxaliplatin pch, Exiplat, Oxaliplatin key, Oxliplatin key, Aspen oxaliplatin, Oxaviatin, Oplaxin, Oxaliplatin medpro, Oxaliplatin fresenius, Eloplat, Oxaliplatin cipla, Oxilico, Recotaxin, Xilaz, Zalitin, Oxaliplatin eurolab, Oxinjo, Eloxatin, Oxaliwin, Oxaliwin rtu

No structure available

This product's active ingredient could not be matched to a single known compound.

Loading Wikipedia summary

Registration

Applicants: 15
Registrations: 50
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Sandoz South Africa (Pty) Ltd2 of 6 cancelled	Oxaliplatin "ebewe", Eloplat	50 mg, 100 mg, 150, 200	410910, 411129, 460919, 460920, 460921, 460922	S4	None
Pharmaplan (Pty) LtdCancelled	Goxyral	50, 100	420596, 420597	S4	None
Eurolab (Pty) Ltd3 of 8 cancelled	Intas-oxaliplatin, Oxilico, Oxaliplatin eurolab	50, 50 mg/10 ml, 100, 100 mg/20 ml, 200, 200 mg/40 ml	421066, 440380, 511096, 511097, 511098, 570147, 570148, 570149	S4	None
Teva Pharmaceuticals (Pty) Ltd	Oxaliplatin pch	50, 100	430102, 430103	S4	None
MSQ Pharma (Pty) Ltd	Exiplat	50, 100	430165, 430166	S4	None
Key Oncologics (Pty) LtdCancelled	Oxaliplatin key, Oxliplatin key	50, 100	450330, 450331	S4	None
Pharmacare limited û woodmead	Aspen oxaliplatin	50 mg/10 ml, 100 mg/20 ml, 200 mg/40 ml	450921, 450922, 450923	S4	None
Safeline Pharmaceuticals (Pty) LtdCancelled	Oxaviatin	50 mg/10 ml, 100 mg/20 ml, 200 mg/40 ml	450934, 450935, 450936	S4	None
Accord Healthcare (Pty) Ltd	Oplaxin	50 mg, 100 mg	460212, 460213	S4	None
Cipla Medpro (Pty) LtdCancelled	Oxaliplatin medpro, Oxaliplatin cipla	50, 100	460477, 460478, 471106, 471107	S4	None
Fresenius Kabi South Africa (Pty) LtdCertificate held by Fresenius Kabi South Africa (Pty) Limited	Oxaliplatin fresenius	1 ml	460897	S4	PIL
Aurogen South Africa (Pty) Ltd	Recotaxin, Xilaz	50 mg/10 ml, 100 mg/20 ml, 200 mg/40 ml	560773, 560774, 560775, 560776.773, 560777.774, 560778.775	S4	None
Innovata pharmaceuticalsCertificate held by Innovata Pharmaceuticals (Pty) Ltd	Zalitin	50, 100	560891, 560892	S4	PI PIL
Hetero Drugs South Africa (Pty) Ltd	Oxinjo	50, 100	590336, 590337	S4	None
Sanofi-aventis South Africa (Pty) LtdCancelled	Eloxatin, Oxaliwin, Oxaliwin rtu	50 mg/10 ml, 100 mg/20 ml	A390497, A390519, A390520, A390521, A390522	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Oxaliplatin "ebewe" 50 MG EACH VIAL CONTAINS OXALIPLATIN 50,0 mg	50 mg	41091041/26/0910	Cancelled	S4	None
Oxaliplatin "ebewe" 100 MG EACH VIAL CONTAINS OXALIPLATIN 100,0 mg	100 mg	41112941/26/1129	Cancelled	S4	None
Goxyral 50 EACH VIAL CONTAINS OXALIPLATIN 50,0 mg	50	42059642/26/0596	Cancelled	S4	None
Goxyral 100 EACH VIAL CONTAINS OXALIPLATIN 100,0 mg	100	42059742/26/0597	Cancelled	S4	None
Intas-oxaliplatin 100 EACH 1,0 ml SOLUTION CONTAINS OXALIPLATIN 5,0 mg	100	42106642/26/1066	Registered	S4	None
Oxaliplatin pch 50 EACH 10,0 ml VIAL CONTAINS OXALIPLATIN 50,0 mg	50	43010243/26/0102	Registered	S4	None
Oxaliplatin pch 100 EACH 20,0 ml VIAL CONTAINS OXALIPLATIN 100,0 mg	100	43010343/26/0103	Registered	S4	None
Exiplat 50 EACH VIAL CONTAINS OXALIPLATIN 50,0 mg	50	43016543/26/0165	Registered	S4	None
Exiplat 100 EACH VIAL CONTAINS OXALIPLATIN 100,0 mg	100	43016643/26/0166	Registered	S4	None
Intas-oxaliplatin 50 EACH VIAL CONTAINS OXALIPLATIN 50,0 mg	50	44038044/26/0380	Registered	S4	None
Oxaliplatin key 50 EACH VIAL CONTAINS OXALIPLATIN 50,0 mg	50	45033045/26/0330	Cancelled	S4	None
Oxliplatin key 100 EACH VIAL CONTAINS OXALIPLATIN 100,0 mg	100	45033145/26/0331	Cancelled	S4	None
Aspen oxaliplatin 50 mg/10 ML EACH VIAL CONTAINS OXALIPLATIN 50,0 mg	50 mg/10 ml	45092145/26/0921	Registered	S4	None
Aspen oxaliplatin 100 mg/20 ML EACH VIAL CONTAINS OXALIPLATIN 100,0 mg	100 mg/20 ml	45092245/26/0922	Registered	S4	None
Aspen oxaliplatin 200 mg/40 ML EACH VIAL CONTAINS OXALIPLATIN 200,0 mg	200 mg/40 ml	45092345/26/0923	Registered	S4	None
Oxaviatin 50 mg/10 ML EACH 10,0 ml SOLUTION CONTAINS OXALIPLATIN 50,0 mg	50 mg/10 ml	45093445/26/0934	Cancelled	S4	None
Oxaviatin 100 mg/20 ML EACH 20,0 ml SOLUTION CONTAINS OXALIPLATIN 100,0 mg	100 mg/20 ml	45093545/26/0935	Cancelled	S4	None
Oxaviatin 200 mg/40 ML EACH 40,0 ml SOLUTION CONTAINS OXALIPLATIN 200,0 mg	200 mg/40 ml	45093645/26/0936	Cancelled	S4	None
Oplaxin 50 MG EACH 1,0 ml SOLUTION CONTAINS :OXALIPLATIN 50,0 mg	50 mg	46021246/26/0212	Registered	S4	None
Oplaxin 100 MG EACH 1,0 ml SOLUTION CONTAINS: OXALIPLATIN 100,0 mg	100 mg	46021346/26/0213	Registered	S4	None
Oxaliplatin medpro 50 EACH VIAL CONTAINS OXALIPLATIN 50,0 mg	50	46047746/26/0477	Cancelled	S4	None
Oxaliplatin medpro 100 EACH VIAL CONTAINS OXALIPLATIN 100,0 mg	100	46047846/26/0478	Cancelled	S4	None
Oxaliplatin 50 mg/10 ML fresenius	1 mlConcentrate for solution for infusion	46089746/26/0897Approved 4 May 2021	Registered	S4	PIL
Eloplat 50 EACH VIAL CONTAINS OXALIPLATIN 50,0 mg	50	46091946/26/0919	Registered	S4	None
Eloplat 100 EACH VIAL CONTAINS OXALIPLATIN 100,0 mg	100	46092046/26/0920	Registered	S4	None
Eloplat 150 EACH VIAL CONTAINS OXALIPLATIN 150,0 mg	150	46092146/26/0921	Registered	S4	None
Eloplat 200 EACH VIAL CONTAINS OXALIPLATIN 200,0 mg	200	46092246/26/0922	Registered	S4	None
Oxaliplatin 50 cipla EACH VIAL CONTAINS OXALIPLATIN 50,0 mg	50	47110647/26/1106	Cancelled	S4	None
Oxaliplatin 100 cipla EACH VIAL CONTAINS OXALIPLATIN 100,0 mg	100	47110747/26/1107	Cancelled	S4	None
Oxilico 50 EACH 1,0 ml SOLUTION CONTAINS: OXALIPLATIN 5,0 mg	50	51109651/26/1096	Cancelled	S4	None
Oxilico 100 EACH 1,0 ml SOLUTION CONTAINS: OXALIPLATIN 5,0 mg	100	51109751/26/1097	Cancelled	S4	None
Oxilico 200 EACH 1,0 ml SOLUTION CONTAINS: OXALIPLATIN 5,0 mg	200	51109851/26/1098	Cancelled	S4	None
Recotaxin 50 mg/10 ML EACH 10,0 ml SOLUTION CONTAINS Oxaliplatin 50,0 mg	50 mg/10 ml	56077356/26/0773	Registered	S4	None
Recotaxin 100 mg/20 ML EACH 20,0 ml SOLUTION CONTAINS Oxaliplatin 100,0 mg	100 mg/20 ml	56077456/26/0774	Registered	S4	None
Recotaxin 200 mg/40 ML EACH 40,0 ml SOLUTION CONTAINS Oxaliplatin 200,0 mg	200 mg/40 ml	56077556/26/0775	Registered	S4	None
Xilaz 50 mg/10 ML EACH 10,0 ml SOLUTION CONTAINS Oxaliplatin 50,0 mg	50 mg/10 ml	560776.77356/26/0776.773	Registered	S4	None
Xilaz 100 mg/20 ML EACH 20,0 ml SOLUTION CONTAINS Oxaliplatin 100,0 mg	100 mg/20 ml	560777.77456/26/0777.774	Registered	S4	None
Xilaz 200 mg/40 ML EACH 40,0 ml SOLUTION CONTAINS Oxaliplatin Oxaliplatin 200,0 mg	200 mg/40 ml	560778.77556/26/0778.775	Registered	S4	None
Zalitin 50 Each vial contains: Oxaliplatin 50,0 mg	50Concentrate for infusion or solution	56089156/26/0891Approved 15 July 2025	Registered	S4	PI PIL
Zalitin 100 Each vial contains: Oxaliplatin 100,0 mg	100Concentrate for infusion or solution	56089256/26/0892Approved 15 July 2025	Registered	S4	PI PIL
Oxaliplatin 50 mg/10 ML eurolab Each 10,0 ml Solution Contain: Oxaliplatin 50,0 mg	50 mg/10 ml	57014757/26/0147	Registered	S4	None
Oxaliplatin 100 mg/20 ML eurolab Each 20,0 mg Solution contains: Oxaliplatin 100,0 mg	100 mg/20 ml	57014857/26/0148	Registered	S4	None
Oxaliplatin 200 mg/40 ML eurolab Each 40,0 mg Solution contains: Oxaliplatin 200,0 mg	200 mg/40 ml	57014957/26/0149	Registered	S4	None
Oxinjo 50 EACH 10,0 ml SOLUTION CONTAINS: OXALIPLATIN 50,0 mg	50	59033659/26/0336	Registered	S4	None
Oxinjo 100 EACH 20,0 ml SOLUTION CONTAINS: OXALIPLATIN 100,0 mg	100	59033759/26/0337	Registered	S4	None
Eloxatin 100 mg/20 ML EACH 1,0 ml SOLUTION CONTAINS OXALIPLATIN 5,0 mg	100 mg/20 ml	A390497A39/26/0497	Cancelled	S4	None
Oxaliwin 50 mg/10 ML EACH 1,0 ml SOLUTION CONTAINS OXALIPLATIN 5,0 mg	50 mg/10 ml	A390519A39/26/0519	Cancelled	S4	None
Oxaliwin 100 mg/20 ML EACH 1,0 ml SOLUTION CONTAINS OXALIPLATIN 5,0 mg	100 mg/20 ml	A390520	Cancelled	S4	None
Oxaliwin 50 mg/10 ML rtu EACH 1,0 ml SOLUTION CONTAINS OXALIPLATIN 5,0 mg	50 mg/10 ml	A390521A39/26/0521	Cancelled	S4	None
Oxaliwin 100 mg/20 ML rtu EACH 1,0 ml SOLUTION CONTAINS OXALIPLATIN 5,0 mg	100 mg/20 ml	A390522A39/26/0522	Cancelled	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Oxaliplatin

S4: Oxaliplatin
Consolidated Schedules 06 July 2026, line 7427

Pharmacological class: Cytostatic agents (class 26)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsZalitin 50, Innovata pharmaceuticals Patient information leaflet (PIL)For patients and carersOxaliplatin 50 mg/10 ML fresenius, Fresenius Kabi South Africa (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background